Table 2.
Results of ancillary examinations.
| Examinations | All patients |
|---|---|
| Brain MRI | Numbers (%) |
| Total abnormal findings | 18 (52.9%) |
| EEG | |
| Abnormal background | |
| Before immunotherapy | 27(79.4%) |
| 3–6months after immunotherapy | 2(5.9%) |
| Last follow up | 0(0%) |
| Interictal Epileptiform Discharge | |
| Before immunotherapy | 16 (47.0%) |
| 3–6months after immunotherapy | 5 (14.7%) |
| Last follow up | 2 (5.8%) |
| EDB | 2 (5.8%) |
| CSF Results | |
| Abnormal findings | 12 (35.3%) |
| Pleocytosis | 11 (32.4%) |
| Increased protein concentration | 7 (20.6%) |
| Pleocytosis and increased protein concentration | 6 (17.6%) |
| Positive OB(Total number 11) | 1 (9.1%) |
EEG, electroencephalogram; EDB, extreme delta brush; CSF, cerebrospinal fluid; OB, Oligoclonal band.